Treatment outcomes and long-term relapse-free survival after multidrug-resistant tuberculosis treatment in Latvia: a retrospective national cohort study
Open Access
- 9 April 2026
- journal article
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 65, 101676
Abstract
No abstract availableKeywords
Funding Information
- Deutsches Zentrum für Infektionsforschung (TTU-TB 02.716)
This publication has 34 references indexed in Scilit:
- Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of LinezolidJournal of Infection, 2025
- Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort studyThe Lancet Infectious Diseases, 2024
- Targeted next-generation sequencing to diagnose drug-resistant tuberculosis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2024
- Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trialThe Lancet Respiratory Medicine, 2023
- Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysisJournal of Infection, 2023
- Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statementThe Lancet Infectious Diseases, 2023
- Long-term treatment outcomes in patients with multidrug-resistant tuberculosisClinical Microbiology and Infection, 2023
- Challenging MDR-TB clinical problems – The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugsInternational Journal of Infectious Diseases, 2019
- Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyondPulmonology, 2018
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987